We narrowed to 430 results for: lenticrispr v2

Showing: 121 - 130 of 430 results

Results per page:

Sort results by:

lentiCRISPR v2-sgMT1E-1

Plasmid

#251690

Purpose

gRNA to knock out MT1E in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

MT1E metallothionein 1E (MT1E Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgMT1E-2

Plasmid

#251691

Purpose

gRNA to knock out MT1E in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

MT1E metallothionein 1E (MT1E Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgLIAS-2

Plasmid

#251682

Purpose

gRNA to knock out LIAS in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

LIAS lipoic acid synthetase (LIAS Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgETS1-1

Plasmid

#251685

Purpose

gRNA to knock out ETS1 in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

ETS1 ETS proto-oncogene 1, transcription factor (ETS1 Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgNFE2L2

Plasmid

#251689

Purpose

gRNA to knock out NFE2L2 in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

NFE2L2 NFE2 like bZIP transcription factor 2 (NFE2L2 Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgMT1X-1

Plasmid

#251692

Purpose

gRNA to knock out MT1X in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

MT1X metallothionein 1X (MT1X Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgMT1X-2

Plasmid

#251693

Purpose

gRNA to knock out MT1X in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

MT1X metallothionein 1X (MT1X Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgFDX1-1

Plasmid

#251679

Purpose

gRNA to knock out FDX1 in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

FDX1 ferredoxin 1 (FDX1 Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgETS1-2

Plasmid

#251686

Purpose

gRNA to knock out ETS1 in mammalian cells

Depositor

Boyi Gan

Article

Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

Insert

ETS1 ETS proto-oncogene 1, transcription factor (ETS1 Human)

Use

CRISPR and Lentiviral

Available Since

Feb. 3, 2026

Availability

Academic Institutions and Nonprofits only

Enlarge
lentiCRISPR v2-sgCrls1-1#

Plasmid

#234765

Purpose

knockout Crls1

Depositor

Judy Lieberman

Article

Miao et al Immunity. 2023 Nov 14;56(11):2523-2541.e

Insert

Crls1 (Crls1 Mouse)

Use

Lentiviral

Available Since

March 27, 2025

Availability

Academic Institutions and Nonprofits only

Enlarge